EDMA
From Wikipedia, the free encyclopedia
EDMA
|
|
Systematic (IUPAC) name | |
? | |
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | ? |
Chemical data | |
Formula | C12H17NO2 |
Mol. mass | 207.2694 |
SMILES | & |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
EDMA, or 3,4-ethylenedioxy-N-methylamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. EDMA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 200mg, and the duration listed as 3-5 hours.[1] EDMA produces hypnogogic imagery and empathogenic, non-psychedelic MDMA-like effects. It generally has a threshold, and no other effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of EDMA.
[edit] References
- ^ Shulgin, Alexander; Ann Shulgin (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.